Log in to your Inderes Free account to see all free content on this page.
Create account

Scandinavian ChemoTech

3.31 SEK

-10.05 %

Less than 1K followers

CMOTEC B

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

-10.05 %
-13.80 %
-16.83 %
-34.06 %
-13.58 %
+61.46 %
-25.11 %
-89.24 %
-91.21 %

Scandinavian ChemoTech is a Swedish company that develops and markets medical technology based on electrochemotherapy for the treatment of cancer. The company offers systems and solutions to clinics in oncology and veterinary medicine and has operations in international markets, including India and Southeast Asia. The company was founded in 2015 and is headquartered in Lund, Sweden.

Read more
Market cap
86.77M SEK
Turnover
178.05K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
11.8.
2026

Interim report Q2'26

27.10.
2026

Interim report Q3'26

23.2.
2027

Annual report '26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.